Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Search

Top

Back to Contracts

Patient Quality of Life (QoL) Clinical Studies

Active

Federal

Response Deadline11/16/2026, 09:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract focuses on conducting patient-centric clinical research for the Defense Health Agency to evaluate factors affecting the quality of life for lupus patients. The scope of work includes comprehensive clinical trial management, the design of patient surveys, psychosocial assessments, and detailed health outcomes research. The primary objective is to generate and deliver clinical study reports and outcome data to prime contractors. The project is categorized under NAICS code 541714 and will be performed in Frederick, Maryland. Interested parties should note that the response deadline is November 16, 2026, following a posting date of October 14, 2026.

General Info

Lupus quality of life clinical research for Defense Health Agency in Frederick, Maryland.

Agency

Department Of Defense → Defense Health Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance

Frederick, MD, 21702, USA

Set-Aside

NONE

Documents

This scope was carved out of HT9427RFI2027LRP.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

RFI Lupus Research Program (LRP) Public

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedOct 14

subcontract

Response DeadlineNov 16

Submission deadline

Response Deadline

11/16/2026, 09:00:00 PM UTCin about 1 month

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → Defense Health Agency

ContactsNo contacts available

OfficeN/A

Organization / AgencyDepartment Of Defense → Defense Health Agency

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Performs clinical research and patient-centric studies for prime contractors on Defense Health Agency (DHA) projects. Identifies factors impacting lupus patient quality of life through clinical trial management, patient survey design, psychosocial assessment, and health outcomes research. Delivers clinical study reports and outcome data.

Similar Contracts

Same NAICS industry code

Preclinical & Translational Research SupportThis subcontract for Preclinical and Translational Research Support involves providing specialized laboratory services and preclinical testing to prime contractors working on Defense Health Agency lupus research projects. The scope of work focuses on supporting the transition from laboratory research to clinical application through the development of animal models, in-vitro and in-vivo modeling, and preclinical toxicity testing. The primary deliverables include validated models and comprehensive preclinical test results. The project is managed under the Department of Defense for the Defense Health Agency and is categorized under NAICS code 541714. Performance of the contract will take place in Frederick, Maryland. Interested parties should note the response deadline of November 16, 2026.

Defense Health Agency

POSTED

about 8 hours ago

DEADLINE

in about 1 month

Disease Mechanism & Intervention ResearchThis subcontract opportunity involves conducting specialized research into lupus disease mechanisms and analyzing patient responses to medical interventions to support prime contractors on Defense Health Agency projects. The scope of work focuses on translational research, pharmacological studies, and the mapping of disease pathways to deliver critical analysis of intervention response data. The project is associated with NAICS code 541714 and will be performed in Frederick, Maryland. Interested parties should note that the solicitation was posted on October 14, 2026, with a response deadline set for November 16, 2026.

Defense Health Agency

POSTED

about 8 hours ago

DEADLINE

in about 1 month

Lupus Genetic & Biological Subset ResearchThe Lupus Genetic and Biological Subset Research subcontract involves providing specialized biological and genetic analysis to support prime contractors on Defense Health Agency research projects. The scope of work focuses on identifying and categorizing lupus patient subsets to enable targeted treatment through genomic sequencing, biomarker identification, biological assay development, and detailed patient cohort analysis. The primary deliverable for this effort is the provision of categorized biological and genetic data sets. This project is managed under the Department of Defense for the Defense Health Agency, with performance taking place in Frederick, Maryland. The opportunity was posted on October 14, 2026, with a response deadline of November 16, 2026. The work is classified under NAICS code 541714, reflecting its focus on research and development in the biotechnology field.

Defense Health Agency

POSTED

about 8 hours ago

DEADLINE

in about 1 month

RFI Lupus Research Program (LRP) Public

Solicitation # HT9427RFI2027LRP

The Defense Health Agency, through the Congressionally Directed Medical Research Programs, has issued a Request for Information under solicitation number HT9427RFI2027LRP to gather feedback for the Lupus Research Program. This initiative aims to inform future focus areas and research funding opportunities for fiscal year 2027. The program is specifically seeking input from academia, industry, non-profit organizations, federal agencies, and the general public to identify critical gaps in the field and underfunded research areas. Strategic goals include improving the quality of life for patients, gaining insight into disease mechanisms and heterogeneity, and advancing the understanding of lupus patient subsets to optimize treatment. This action is strictly for information and planning purposes and does not constitute a formal solicitation, request for proposals, or request for quotations. Consequently, no contract will be awarded based on this announcement, and there are no established deliverables or periods of performance. Interested parties are requested to provide their feedback via Survey Monkey by November 16, 2026, at 4:00 PM EST. While previous appropriations from fiscal years 2017 through 2026 totaled 75 million dollars, funds for fiscal year 2027 have not yet been appropriated.

Defense Health Agency

POSTED

about 8 hours ago

DEADLINE

in about 1 month

Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)

Solicitation # RFA-AI-28-024

The National Institutes of Health, under the Department of Health and Human Services, is soliciting applications for RFA-AI-28-024 to support the research and preclinical development of highly efficacious malaria vaccines. The initiative focuses on utilizing structure-based immunogen design, improved formulations, and combination vaccines to create long-lasting protection that can serve as a model for other mosquito-borne diseases. This funding opportunity is structured as a phased award, consisting of an R61 exploratory phase for up to three years with annual direct costs up to 400,000 dollars, and an R33 development phase for up to two years with annual direct costs up to 750,000 dollars. The maximum total project period is five years, and clinical trials are strictly prohibited. Applications will be evaluated through the NIH peer review system based on the importance of the research, rigor and feasibility of the approach, and the expertise of the investigators and their environment. Key requirements include the establishment of quantifiable R61 transition milestones and clear translational Go/No-go criteria for vaccine candidates. Applicants must maintain active SAM registration and provide a Data Management and Sharing Plan. Additionally, recipients must adhere to strict cybersecurity protocols modeled after the NIST framework, including multifactor authentication and a 48-hour incident notification requirement, and ensure all research involving human subjects or vertebrate animals complies with federal regulations and ethical guidelines.

National Institutes Of Health

POSTED

DEADLINE

High-Throughput Functional Genomic AssayingThis subcontract, titled High-Throughput Functional Genomic Assaying, supports National Institutes of Health and NHGRI research projects by providing experimental testing of genomic variants. The scope of work involves implementing high-throughput assays to perturb variants and executing functional interpretation strategies utilizing CRISPR-based systems and high-throughput screening platforms. The selected provider is responsible for delivering raw molecular and cellular data along with all associated metadata. The project is managed under the Department of Health and Human Services and requires strict adherence to 45 CFR Part 46 regulations regarding human subjects research. The opportunity was posted on October 9, 2026, with a response deadline of December 14, 2026. It is categorized under NAICS code 541714 for research and development in biotechnology.

National Institutes Of Health

POSTED

DEADLINE

Specialized Phenotypic Assay Development/ExecutionThis subcontract, titled Specialized Phenotypic Assay Development/Execution, supports prime contractors on NIH IGVF Consortium projects under the Department of Health and Human Services. The primary objective is the collection of robust phenotypic data through the execution of imaging, proteomics, and transcriptomics assays designed to measure the impacts of variant interactions. To achieve this, the contractor will utilize advanced technical equipment, including mass spectrometers, flow cytometers, and high-content imaging systems. The scope of work emphasizes the delivery of high-quality phenotypic data sets while adhering to strict quality control standards for high-throughput data. This opportunity falls under NAICS code 541714 and was posted on October 9, 2026, with a response deadline of December 14, 2026.

National Institutes Of Health

POSTED

DEADLINE

Senescence-Specific Reagent and Tool ManufacturingThis subcontract, titled Senescence-Specific Reagent and Tool Manufacturing, supports National Institutes of Health projects focused on senescence technologies. The selected provider will develop and supply innovative reagents, biospecimens, and tools for prime contractors, specifically focusing on the creation of markers for phenotypic identifiers and the manufacture of reagents to identify senescence heterogeneity within secretomes and tissue environments. The scope of work requires the use of biotechnology laboratory facilities for antibody production and protein synthesis, with a final delivery of validated assays and physical reagents. All operations must strictly adhere to NIH guidelines regarding human systems. The opportunity was posted on October 9, 2026, with a response deadline of November 23, 2026, falling under NAICS code 541714.

National Institutes Of Health

POSTED

DEADLINE

in about 1 month

Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)

Solicitation # RFA-RM-27-007

The National Institutes of Health, under the Department of Health and Human Services, is soliciting the development or adaptation of innovative senescence technologies (SenTecs) through solicitation RFA-RM-27-007. These technologies aim to identify, characterize, and understand senescent cell heterogeneity within tissue environments and secretomes to improve strategies for modulating these cells in human aging and disease. The program utilizes a five-year, milestone-driven award structure divided into two phases: a two-year UG3 phase focused on development and feasibility, and a three-year UH3 phase dedicated to optimization, refinement, and validation. Transition to the UH3 phase is not automatic and requires an administrative review at the end of year two. The final year of the award requires a collaborative demonstration project within the SenNet consortium. The NIH intends to commit 5.4 million dollars in total costs for fiscal year 2027 to fund up to nine awards, with direct cost caps of 400,000 dollars per year for the UG3 phase and 550,000 dollars per year for the UH3 phase. Applications are evaluated based on the importance of the research, scientific rigor, feasibility, and the expertise of the investigators. Required submissions include an Intellectual Property Strategy and a Data Management and Sharing Plan. Awardees must adhere to strict cybersecurity incident reporting, maintain a seven-year confidentiality agreement for non-public information, and ensure all technical assets and data are deposited into the SenNet Data Portal. Clinical trials are not allowed under this specific opportunity.

National Institutes Of Health

POSTED

DEADLINE

in about 1 month

IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)

Solicitation # RFA-HG-27-008

The National Human Genome Research Institute (NHGRI), under the Department of Health and Human Services, is soliciting applications for the Impact of Genomic Variation on Function (IGVF) Data and Coordinating Center (DACC) via solicitation RFA-HG-27-008. The DACC will serve as the central hub for the IGVF Consortium, tasked with developing a comprehensive, searchable catalog of genomic function and variant impacts and managing a data portal for housing and sharing consortium resources. Key technical objectives include the hardening of data processing pipelines to ensure they are containerized, robust, and reproducible, while adopting existing data and metadata standards to promote interoperability. The NHGRI intends to commit 6 million dollars in total costs for the period of FY 2027-2031, with annual application budgets limited to 4 million dollars in direct costs. Funding decisions are based on scientific peer review and program-specific considerations, focusing on technical merit, synergy with other IGVF projects, and the applicant's capability to coordinate large-scale genomic data efforts. Applicants must maintain active registrations in SAM, eRA Commons, and Grants.gov, and all Principal Investigators must have a linked ORCID ID. Special requirements include a dedicated Project Manager devoting at least 6 person months and strict adherence to the Cybersecurity Act of 2015, which mandates reporting cybersecurity incidents within 48 hours of discovery. Proposals must include a Research Strategy limited to 30 pages and be submitted via an institutional system-to-system solution by the December 14, 2026, deadline.

National Institutes Of Health

POSTED

DEADLINE

Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)

Solicitation # RFA-RM-27-016

The National Institutes of Health (NIH) is soliciting applications under RFA-RM-27-016 to establish SenNet Discovery and Validation Centers (DVCs) as part of Stage 2 of the Cellular Senescence Network. The primary objective of these centers is to define, refine, and validate tissue- and disease-relevant cellular senescence signatures, known as senotypes, and their associated biomarkers. DVCs are required to investigate the functional consequences of these signatures in human health and disease, generate high-quality molecular, cellular, and spatial datasets for public release via the Data Coordination and Informatics Center, and execute consortium-wide organizational and outreach activities. The maximum project period is five years, with application budgets limited to approximately 3 million dollars in direct costs per year. A specific requirement includes a mandatory 600,000 dollar annual direct cost allocation for the SenNet Organization and Outreach Component, of which 40 to 45 percent must support educational programs. Additionally, starting in Year 2, centers must set aside approximately 10 percent of their total budget for cross-consortium validation. Applications are evaluated through the NIH peer review system based on significance, approach, and the protection of human subjects, with performance measured annually by the successful acceptance and public release of data. Applicants must maintain active registrations in the System for Award Management and eRA Commons. Required submission materials include a 30-page application divided into four elements covering vision, preclinical modeling, biospecimen management, and outreach, along with letters of support and human subjects documentation where applicable. Awardees must adhere to strict data security protocols, including a seven-year confidentiality disclosure agreement and a requirement to report cybersecurity incidents within 48 hours.

National Institutes Of Health

POSTED

DEADLINE

in about 1 month

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Solicitation # RFA-HG-27-007

The National Institutes of Health, through the Department of Health and Human Services, is soliciting applications under RFA-HG-27-007 to establish centers for the Impact of Genomic Variation on Function (IGVF) Consortium. The primary objective is to characterize genomic variation and assess how individual variants in DNA, RNA, or protein-coding elements impact genome function and phenotypes. Funded centers will utilize high-throughput methods to perturb variants, collect molecular and cellular data, and develop portable data processing pipelines. These centers are expected to collaborate within the consortium to coordinate assays and cell types, contributing raw and processed data to the IGVF Catalog via the Data Analysis and Coordination Center. The funding cycle runs from 2027 through fiscal year 2031, with a maximum project period of five years and budgets limited to 2 million dollars in direct costs per year. Notably, 20 percent of direct costs must be allocated to support collaborative work. Applications are evaluated based on scientific merit through the NIH peer review system and a second level of review by the National Advisory Council for Human Genome Research, focusing on significance, overall impact, and the utility of the proposed assays. Clinical trials are not allowed, and research involving human subjects must comply with 45 CFR Part 46. Applicants must maintain active registrations in the System for Award Management and eRA Commons, and all Principal Investigators must have a linked ORCID ID. Required submissions include a Research Strategy limited to 30 pages, a Resource Sharing Plan, and a Data Management and Sharing Plan. Key personnel requirements include a minimum of three person-months of effort for the PD/PI and a dedicated Project Manager committing at least four person-months. Additionally, awardees must implement a cybersecurity incident response plan with a 48-hour notification requirement for any discovered incidents.

National Institutes Of Health

POSTED

DEADLINE

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

Premier Shockwave Notice of Intent

Solicitation # HT940827Q0001

The Defense Health Agency, through the Healthcare Contracting Division in San Antonio, intends to award a sole source contract to Premier Shockwave to support Wilford Hall Medical Center. The contract is for the procurement of the OssaTron, a medical device designed to deliver high-energy extracorporeal shock wave therapy for chronic orthopedic conditions such as chronic plantar fasciitis and chronic lateral epicondylitis. This requirement is intended to cover a five-year period of service. The procurement falls under NAICS code 334510 for Electromedical and Electrotherapeutic Apparatus Manufacturing. While this notice serves as an intent to award a sole source contract rather than a formal solicitation for quotes, the agency is accepting capability statements and proposals from responsible sources for consideration in future requirements. The response deadline for such submissions is October 28, 2026.

Electromedical and Electrotherapeutic Apparatus Manufacturing

POSTED

about 8 hours ago

DEADLINE

Steris Sterilizer Maintenance/Service at Offutt AFB, NE

Solicitation # HT940726Q0001

The Defense Health Agency Contracting Activity Central Division is soliciting quotations for a single-award, Firm-Fixed-Price commercial service contract to provide comprehensive maintenance and repair services for Government-owned Steris sterilization and washer equipment. Located at the 55th Medical Group, Ehrling Bergquist Clinic at Offutt Air Force Base, Nebraska, the scope of work includes scheduled preventive maintenance, safety inspections, calibrations, annual chamber cleanings, and unscheduled emergency repairs. Covered equipment consists of three Steris AMSCO 400 Steam Sterilizers, one Steris Reliance Vision Single Chamber Washer Disinfector, two Steris AMSCO 7052HP Single Chamber Washer Disinfectors, and two Steris IWECO5 Ultrasonic Instrument Washers. Services must be performed by certified technicians using genuine OEM or approved equivalent parts. This procurement is a 100 percent Total Small Business Set-Aside under NAICS 811210 and 811211. The anticipated period of performance includes one 12-month base period, four 12-month option periods, and a potential six-month extension, running from November 1, 2026, through April 30, 2032. Award will be determined using the Lowest Price Technically Acceptable (LPTA) method, with the Total Evaluated Price encompassing the base period, all option years, and the six-month extension. Technical acceptability is based on a pass/fail evaluation of the contractor's personnel qualifications, OEM resource access, and ability to meet a 48-business-hour emergency response standard and a 95 percent monthly equipment uptime requirement. Quotations are due electronically by October 19, 2026, at 2:00 PM Eastern Time.

Electronic and Precision Equipment Repair and Maintenance

POSTED

DEADLINE

MTEC Solicitation Summary: Fiscal Year 2026 Multi-Topic Request for Project Proposals

Solicitation # MTEC-26-04-MultiTopic

The Medical Technology Enterprise Consortium (MTEC), in collaboration with the Defense Health Agency, is soliciting project proposals under solicitation MTEC-26-04-MultiTopic for medical prototype technological and knowledge solutions. Authorized under 10 U.S.C. section 4022 and utilizing an Other Transaction Agreement, this effort seeks to modernize medical capabilities to maintain force readiness and soldier lethality in future multi-domain conflicts. The solicitation covers 16 distinct Focus Areas, including behavioral health, physical fitness, wound infection prevention, sepsis treatment, musculoskeletal injury interventions, non-addictive analgesics, blast and blunt impact sensors, and a multisite clinical biomarker platform for lung and kidney failure. Proposals are submitted via a two-stage Enhanced White Paper process, where selected Stage 1 submissions are invited to provide full cost proposals in Stage 2. To be eligible, projects must demonstrate clear military relevance, meet a minimum Knowledge/Technology Readiness Level of 3, and fit the specific definition of a prototype rather than being exploratory. Additionally, solutions must not have been submitted to MTEC within the last two years. While average initial awards range from 2.0 to 3.5 million dollars over a two to three year period, specific funding and performance periods vary by Focus Area. Teaming is encouraged, and successful projects may be eligible for non-competitive follow-on tasks.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Laundry-Linen Services at Dover AFB

Solicitation # HT001427QE001

Industrial Launderers

POSTED

DEADLINE

Inhaled Nitric Oxide

Solicitation # HT940827Q0002

The Defense Health Agency intends to award a sole source contract to INO Therapeutics LLC for the procurement and delivery of Inhaled Nitric Oxide for the Department of Medicine at Brooke Army Medical Center in Fort Sam Houston, Texas. The contract covers a base period from January 1, 2027, to December 31, 2027, with four additional option years. The scope of work includes the supply of 800 PPM nitric oxide for inhalation, a specialized delivery device, all necessary maintenance and calibration accessories, and comprehensive support services such as training and logistics. This notice serves as a sources-sought inquiry to determine if other capable vendors exist before finalizing the sole source award. Interested parties must submit written evidence of their capability to meet all technical requirements to Contracting Officer Joe D. Wells by October 22, 2026, at 12:00 PM CST. Submissions must demonstrate that competition would be beneficial to the government without being cost or schedule prohibitive.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Genuine Steris OEM Parts and PM Kits SupplyThis subcontract, issued by the Defense Health Agency under the Department of Defense, focuses on the supply of authentic, FDA-approved Original Equipment Manufacturer parts, lubricants, and preventive maintenance kits. The scope specifically covers genuine Steris replacement components for AMSCO 400, Reliance Vision, AMSCO 7052HP, and IWECO5 models to support prime contractors on facility projects located at Offutt AFB. All provided materials must be non-generic and delivered directly to the prime contractor or the facility. The opportunity is designated as a Total Small Business Set Aside under NAICS code 423450. Interested parties should note the response deadline of October 19, 2026. Performance of the contract will take place in zip code 68113.

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

DEADLINE

Steris Sterilizer and Washer Maintenance & Repair ServicesThis small business set-aside subcontract involves providing specialized maintenance and repair services for Steris sterilizers and washers at Offutt Air Force Base for the Defense Health Agency. The scope of work includes performing scheduled annual preventive maintenance, calibrations, safety inspections, and unscheduled corrective repairs. Specifically, the contractor is responsible for quarterly preventive maintenance, annual chamber cleanings, and rapid diagnosis of Steris AMSCO 400, Reliance Vision, and IWECO5 systems. To ensure equipment is delivered in fully serviceable condition, the contractor must possess Steris manufacturer certification and utilize OEM diagnostic software. All work must be documented through detailed service reports. This opportunity is categorized under NAICS code 811219 and is intended for prime contractors managing facility projects at the specified location.

Other Electronic and Precision Equipment Repair and Maintenance

POSTED

DEADLINE

Technical Documentation & Knowledge ManagementThe Technical Documentation and Knowledge Management subcontract supports the Defense Health Agency within the Department of Defense. The primary objective is the creation and maintenance of critical technical blueprints and operational guides for prime contractors, specifically focusing on the development of runbooks, architecture diagrams, and Interface Control Documents to ensure effective platform sustainment. Personnel assigned to this effort must possess a Tier 1-3 Security Clearance to perform the required duties. The contract is categorized under NAICS code 541611, with a response deadline set for October 28, 2026. Success is measured by the delivery of completed technical documentation and architectural assets.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS